Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice

Nat Clin Pract Oncol. 2005 May;2(5):255-61. doi: 10.1038/ncponc0172.


Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.

Publication types

  • Review

MeSH terms

  • Androgens / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antioxidants / pharmacology*
  • Chemoprevention*
  • Diet
  • Enzyme Inhibitors / therapeutic use
  • Epidemiologic Studies
  • Finasteride / therapeutic use
  • Humans
  • Inflammation
  • Male
  • Prostatic Neoplasms / physiopathology*
  • Prostatic Neoplasms / prevention & control*
  • Randomized Controlled Trials as Topic


  • Androgens
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Enzyme Inhibitors
  • Finasteride